triazoles has been researched along with transforming growth factor alpha in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hester, S; Moore, T; Murphy, L; Nesnow, S; Padgett, WT; Wood, CE | 1 |
| Ebi, H; Kita, K; Matsumoto, K; Nanjo, S; Takeuchi, S; Tanimoto, A; Yamada, T; Yano, S | 1 |
2 other study(ies) available for triazoles and transforming growth factor alpha
| Article | Year |
|---|---|
The hepatocarcinogenic conazoles: cyproconazole, epoxiconazole, and propiconazole induce a common set of toxicological and transcriptional responses.
Topics: Administration, Oral; Animals; Carcinogens; Cell Proliferation; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Epoxy Compounds; Fungicides, Industrial; Gene Expression Regulation, Neoplastic; Hepatocytes; Liver; Male; Mice; Mice, Inbred Strains; Oligonucleotide Array Sequence Analysis; Transforming Growth Factor alpha; Triazoles | 2012 |
Receptor ligand-triggered resistance to alectinib and its circumvention by Hsp90 inhibition in EML4-ALK lung cancer cells.
Topics: Benzoquinones; Blotting, Western; Carbazoles; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Epidermal Growth Factor; ErbB Receptors; Hepatocyte Growth Factor; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Ligands; Lung Neoplasms; Mutation; Oncogene Proteins, Fusion; Phosphorylation; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Transforming Growth Factor alpha; Triazoles | 2014 |